The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease

Background There are limited number of studies that investigate clinical variables instead of chronic obstructive lung disease (COPD) management according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 classification. The aim of the study was to investigate whether there...

Full description

Bibliographic Details
Main Authors: Ipek Candemir, M.D., Pinar Ergun, M.D., Dicle Kaymaz, M.D., Filiz Tasdemir, Nurcan Egesel
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2018-10-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
Online Access:https://e-trd.org/search.php?where=aview&id=10.4046/trd.2017.0114&code=0003TRD&vmode=FULL
id doaj-d0ebf3dcbabb4136b6c3af6226b7d321
record_format Article
spelling doaj-d0ebf3dcbabb4136b6c3af6226b7d3212020-11-25T02:41:40ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842018-10-01814281288The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease Ipek Candemir, M.D.0Pinar Ergun, M.D.1Dicle Kaymaz, M.D.2Filiz Tasdemir3Nurcan Egesel4Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Pulmoner Rehabilitation and Home Care Center, Ankara, Turkey.Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Pulmoner Rehabilitation and Home Care Center, Ankara, Turkey.Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Pulmoner Rehabilitation and Home Care Center, Ankara, Turkey.Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Pulmoner Rehabilitation and Home Care Center, Ankara, Turkey.Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Pulmoner Rehabilitation and Home Care Center, Ankara, Turkey. Background There are limited number of studies that investigate clinical variables instead of chronic obstructive lung disease (COPD) management according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 classification. The aim of the study was to investigate whether there was a difference between GOLD 2017 classification and spirometric stage in clinical variables in patients with COPD. The data of 427 male patients with stable COPD were investigated retrospectively. Methods Patients were allocated into combined assessment of GOLD 2017 and spirometric stage. Age, amount of smoking, pulmonary function, modified Medical Research Council (mMRC), incremental shuttle walk test (ISWT), Hospital Anxiety-Depression Scale (HADS), St. George's Respiratory Questionnaire (SGRQ), body mass index (BMI), and fat free mass index (FFMI) were recorded. Results Seventy-three (17%) patients were in group A, 103 (24%) constituted group B, 38 (9%) were included in group C, and 213 (50%) comprised group D according to the combined assessment of GOLD 2017. Twenty-three patients (5%) were in stage 1, 95 (22%) were in stage 2, 149 (35%) were in stage 3, and 160 (38%) were in stage 4 according to spirometric stage. According to GOLD 2017, age, amount of smoking, mMRC, BMI, FFMI, SGRQ, HADS, forced vital capacity, forced expiratory volume in 1 second (FEV1), and ISWT were significantly different between groups. Ages, amount of smoking, FFMI, BMI, HADS of group A were different from B and D. Smiliar values of FEV1 were found in A–C and B–D. A and C had smiliar ISWT. According to spirometric stage, BMI, FFMI of stage 4 were statistically different. mMRC, ISWT, and SGRQ of stages 3 and 4 were different from other stages, amongst themselves. FEV1 was correlated with mMRC, SGRQ, anxiety scores, BMI, FFMI, and ISWT. Conclusion This study showed that the GOLD ABCD classification might not represent the severity of COPD sufficiently well in terms of lung function or exercise capacity. The combination of both spirometric stage and combined assessment of GOLD 2017 is important, especially for estimating clinical variables. https://e-trd.org/search.php?where=aview&id=10.4046/trd.2017.0114&code=0003TRD&vmode=FULLpulmonary diseasechronic obstructivequality of lifedyspnea
collection DOAJ
language English
format Article
sources DOAJ
author Ipek Candemir, M.D.
Pinar Ergun, M.D.
Dicle Kaymaz, M.D.
Filiz Tasdemir
Nurcan Egesel
spellingShingle Ipek Candemir, M.D.
Pinar Ergun, M.D.
Dicle Kaymaz, M.D.
Filiz Tasdemir
Nurcan Egesel
The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
Tuberculosis and Respiratory Diseases
pulmonary disease
chronic obstructive
quality of life
dyspnea
author_facet Ipek Candemir, M.D.
Pinar Ergun, M.D.
Dicle Kaymaz, M.D.
Filiz Tasdemir
Nurcan Egesel
author_sort Ipek Candemir, M.D.
title The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
title_short The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
title_full The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
title_fullStr The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
title_full_unstemmed The Comparison of Clinical Variables in Two Classifications: GOLD 2017 Combined Assessment and Spirometric Stage of Chronic Obstructive Pulmonary Disease
title_sort comparison of clinical variables in two classifications: gold 2017 combined assessment and spirometric stage of chronic obstructive pulmonary disease
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
series Tuberculosis and Respiratory Diseases
issn 1738-3536
2005-6184
publishDate 2018-10-01
description Background There are limited number of studies that investigate clinical variables instead of chronic obstructive lung disease (COPD) management according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 classification. The aim of the study was to investigate whether there was a difference between GOLD 2017 classification and spirometric stage in clinical variables in patients with COPD. The data of 427 male patients with stable COPD were investigated retrospectively. Methods Patients were allocated into combined assessment of GOLD 2017 and spirometric stage. Age, amount of smoking, pulmonary function, modified Medical Research Council (mMRC), incremental shuttle walk test (ISWT), Hospital Anxiety-Depression Scale (HADS), St. George's Respiratory Questionnaire (SGRQ), body mass index (BMI), and fat free mass index (FFMI) were recorded. Results Seventy-three (17%) patients were in group A, 103 (24%) constituted group B, 38 (9%) were included in group C, and 213 (50%) comprised group D according to the combined assessment of GOLD 2017. Twenty-three patients (5%) were in stage 1, 95 (22%) were in stage 2, 149 (35%) were in stage 3, and 160 (38%) were in stage 4 according to spirometric stage. According to GOLD 2017, age, amount of smoking, mMRC, BMI, FFMI, SGRQ, HADS, forced vital capacity, forced expiratory volume in 1 second (FEV1), and ISWT were significantly different between groups. Ages, amount of smoking, FFMI, BMI, HADS of group A were different from B and D. Smiliar values of FEV1 were found in A–C and B–D. A and C had smiliar ISWT. According to spirometric stage, BMI, FFMI of stage 4 were statistically different. mMRC, ISWT, and SGRQ of stages 3 and 4 were different from other stages, amongst themselves. FEV1 was correlated with mMRC, SGRQ, anxiety scores, BMI, FFMI, and ISWT. Conclusion This study showed that the GOLD ABCD classification might not represent the severity of COPD sufficiently well in terms of lung function or exercise capacity. The combination of both spirometric stage and combined assessment of GOLD 2017 is important, especially for estimating clinical variables.
topic pulmonary disease
chronic obstructive
quality of life
dyspnea
url https://e-trd.org/search.php?where=aview&id=10.4046/trd.2017.0114&code=0003TRD&vmode=FULL
work_keys_str_mv AT ipekcandemirmd thecomparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT pinarergunmd thecomparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT diclekaymazmd thecomparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT filiztasdemir thecomparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT nurcanegesel thecomparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT ipekcandemirmd comparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT pinarergunmd comparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT diclekaymazmd comparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT filiztasdemir comparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
AT nurcanegesel comparisonofclinicalvariablesintwoclassificationsgold2017combinedassessmentandspirometricstageofchronicobstructivepulmonarydisease
_version_ 1724777281376747520